• iGenomics: Free Genome Analysis For The iPhone

    Bio-IT World | Sequencing in the palm of your hand is now a reality. A team of researchers has created iGenomics—the first comprehensive mobile genome analysis application, with capabilities to align reads, call variants, and visualize the results entirely on an iOS device. What started as a high school student’s internship project is now freely available in the App Store.

    Dec 15, 2020

  • New AI Chips, Managed Services Among Flood from AWS at re:Invent 2020

    Bio-IT World | At its re:Invent 2020 event, Amazon AWS announced many new products and services including the new Trainium chip for machine learning.

    Dec 14, 2020

  • Oral Antiviral Blocks Transmission, Multi-Organ Failure Mechanisms, Molecular Target for Lung Fibrosis: COVID-19 Updates

    Bio-IT World I IgA antibodies dominate early neutralizing response, specific proteins in animals increase vulnerability, understanding the roles of antibodies and T cells, and Molnupiravir could block SARS-CoV-2 transmission. Plus: New biomedical data sharing platform, disrupting cholesterol processes may combat COVID-19, and a new project aims to understand formation of coronaviruses.

    Dec 11, 2020

  • All of Us Returns First Genetic Results To Participants

    Bio-IT World | The All of Us Research Program has begun to return genetic results to participants who have donated biosamples for research, NIH announced yesterday. The program prioritizes information return to its research volunteers. Initially, participants can choose to receive information about their genetic ancestry and traits, with health-related results available at a later date.

    Dec 10, 2020

  • We’re All In This Together: The Integral Role of Animal Biology and Human Health

    Bio-IT World | COVID-19 has brought the link between animals and humans to the forefront, but given that we share more than 97% of our DNA with mammals, it’s time that we begin to consider diverse animal models not from a perspective of simply modeling human disease, but from a perspective of novel discovery and leveraging unique biology to find new pathways for therapeutics.

    Dec 10, 2020